A pH-independent instantaneous release of flurbiprofen: a study of the preparation of complexes, their characterization and in vitro/in vivo evaluation.

In this study, furbiprofen/hydroxypropyl-beta-cyclodextrin (HP beta CD) inclusion complexes were prepared to improve the drug dissolution and facilitate its application in hydrophilic gels. Inclusion complexes were prepared using a supercritical fluid processing and a conventional optimized co-lypholization method was employed as a reference. The entrapment efficacy and drug loading of both methods were investigated. Evaluation of drug dissolution enhancement was conducted in deionized water as well as buffer solutions of different pH. Carbopol 940 gels of both flurbiprofen and flurbiprofen/HP beta CD inclusion complexes, with or without penetration enhancers, were prepared and percutaneous permeation studies were performed using rat abdominal skin samples. Formation of flurbiprofen/HPbCD inclusion complexes was confirmed by Fourier transform-infrared spectroscopy, differential scanning calorimetry, X-ray diffraction and scanning electron microscopy. The results obtained showed that SCF processing produced a higher EE (81.91 +/- 1.54%) and DL (6.96 +/- 0.17%) compared with OCL with values of 69.11 +/- 2.23% and 4.00 +/- 1.01%, respectively. A marked instantaneous release of flurbiprofen/ HP beta CD inclusion complexes prepared by SCF processing (103.04 +/- 2.66% cumulative release within 5 min, a 10-fold increase in comparison with flurbiprofen alone) was observed. In addition, this improvement in dissolution was shown to be pH-independent (the percentage cumulative release at pH 1.2, 4.5, 6.8 and 7.4 at 5 min was 95.19 +/- 1.71, 101.75 +/- 1.44, 105.37 +/- 4.58 and 96.84 +/- 0.56, respectively). Percutaneous permeability of flurbiprofen-in-HP beta CD-in-gels could be significantly accelerated by turpentine oil and was related to the water content in the system. An in vivo pharmacokinetic study showed a 2-fold increase in C-max and a shortened T-max as well as a comparable relative bioavailability when compared with the commercial flurbiprofen Cataplasms (Zepolas (R)). With their superior dissolution, these flurbiprofen/HP beta CD inclusion complexes prepared by SCF processing could provide improved applications for flurbiprofen.